Provider Training for ACE Discussions in Child Development

Overseen By Abigail Lott, PhD, ABPP

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Emory University

Disqualifiers: Non-English/Spanish speakers, Under 18, Others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 6

181 Participants Needed

Trial Summary

What is the purpose of this trial?

This study will see if asking caregivers about their difficult childhood experiences and discussing these with doctors can help improve the health of their infants. The study focuses on caregivers of infants at a clinic serving mostly Hispanic families. The goal is to see if understanding and talking about past hardships can lead to better parenting and healthier children.

Research Team

Abigail Lott, PhD, ABPP

Principal Investigator

Emory University

Eligibility Criteria

This study is for caregivers bringing children to specific well-child checkups (4, 6, 9, 15, or 18 months) at the MCC. Participants should be able to speak and read English or Spanish fluently. Caregivers under age 18 or previously enrolled with another child are excluded.

Inclusion Criteria

I am bilingual as per Emory's Spanish fluency tests.

I am of Hispanic origin and primarily speak Spanish.

Caregivers will be eligible to enroll in the study if they bring children to the MCC for either a 4-month, 6-month, 9-month, 15-month, or 18-month WCC

Exclusion Criteria

I am over 18 years old.

Caregivers will be excluded if they have already been enrolled in the study protocol via another child or prior WCC

I can speak and read either English or Spanish.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

1 visit (in-person)

Intervention

Caregivers undergo ACEs screening and participate in provider-led discussions during well-child visits

18 months

Multiple visits (in-person) at 4, 6, 9, 15, and 18 months

Follow-up

Participants are monitored for changes in child health outcomes and caregiver resilience

18 months

Follow-up assessments at 1 week, 6 months, and 18 months

Treatment Details

Interventions

• Training for ACEs and study procedures
• Training on study procedures

Trial Overview The trial tests if caregiver training on Adverse Childhood Experiences (ACEs) can reduce their children's emergency visits and missed appointments by increasing awareness of ACEs' impact on child health.

Participant Groups

Group I: Intervention Arm Experimental Treatment 1 Intervention

Intervention providers will undergo training for ACEs screening and discussion. Eligible families will be enrolled into the study at the intake of their child's 4-month, 6-month, 9-month, 15-month, or 18-month well child check. Caregivers will complete the intake surveys including demographics, caregiver ACEs, resilience, warmth, PTSD, and depression. The providers will lead a discussion regarding the impact of caregiver ACEs. Patients will be contacted 1-week, 6-months, and 18-months following their enrollment to obtain repeat measures of the survey instruments. At the 18-month time point, the electronic medical record (EMR) will be queried to obtain outcome measures.

Group II: Standard of Care Arm Active Control 1 Intervention

During the study period, standard of care providers will continue to provide standard of care treatment(s); however, families receiving care from the standard of care providers will complete all study surveys. Instead of ACEs training, standard of care providers will undergo training on study procedures including obtaining survey instruments from caregivers and proper storage of survey instruments. This training will stress the importance of not reviewing caregiver ACE scores and minimizing possible treatment contamination. However, standard of care providers will still be able to provide resources to the families as part of standard of care.

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials

1,735

Recruited

2,605,000+

Centers for Disease Control and Prevention

Collaborator

Trials

902

Recruited

25,020,000+